Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-000242
Filing Date
2025-01-10
Accepted
2025-01-10 15:12:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3009
  Complete submission text file 0001959173-25-000242.txt   4438
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Subject) CIK: 0001434316 (see all company filings)

EIN.: 651311552 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36076 | Film No.: 25522540
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O FATE THERAPEUTICS, INC. 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address
Bressi Jerome Charles (Reporting) CIK: 0002034505 (see all company filings)

Type: 144